Shan, B., Shen, X., Jin, W., Dong, M., Han, X., Lin, L., . . . Pan, Y. (2020). Standard-dose epirubicin increases the pathological complete response rate in neoadjuvant chemotherapy for breast cancer: A multicenter retrospective study. Gland Surg.
Chicago Style CitationShan, Ben-Jie, et al. "Standard-dose Epirubicin Increases the Pathological Complete Response Rate in Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter Retrospective Study." Gland Surg 2020.
MLA CitationShan, Ben-Jie, et al. "Standard-dose Epirubicin Increases the Pathological Complete Response Rate in Neoadjuvant Chemotherapy for Breast Cancer: A Multicenter Retrospective Study." Gland Surg 2020.
Warning: These citations may not always be 100% accurate.